Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine.
Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine. Pediatr Infect Dis J. 2010 Feb; 29(2):95-101.
View in:
PubMed
subject areas
Adolescent
Adolescent
Adult
Adult
Child
Child
Drug-Related Side Effects and Adverse Reactions
Drug-Related Side Effects and Adverse Reactions
Female
Female
Fever
Fever
Headache
Headache
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Humans
Humans
Incidence
Incidence
Male
Male
Pain
Pain
Papillomavirus Infections
Papillomavirus Infections
Papillomavirus Vaccines
Papillomavirus Vaccines
Placebos
Placebos
Product Surveillance, Postmarketing
Product Surveillance, Postmarketing
United States
United States
Vaccines, Virosome
Vaccines, Virosome
Young Adult
Young Adult
authors with profiles
Michael A Gold